Veness Adam M bought DNTH
August 7, 2026 · Form 4 insider transaction
Veness Adam M bought 3,833 shares of Dianthus Therapeutics, Inc. at $17.88 per share, a transaction worth $68.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,833
Price
$17.88
Total value
$68.5K
InsiderVeness Adam M
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 7, 2026
Filing dateAugust 11, 2026
Shares owned after3,833
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026.